SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS/A - Annual Report to Security Holders: [Amend]
SEC Accession No. 0001213900-24-037204
Filing Date
2024-04-29
Accepted
2024-04-29 16:30:20
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-29

Document Format Files

Seq Description Document Type Size
1 AMENDMENT TO ANNUAL REPORT ea0204358-03.pdf ARS/A 555342
  Complete submission text file 0001213900-24-037204.txt   766263
Mailing Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037
Business Address 2200 PENNSYLVANIA AVE NW SUITE 300E WASHINGTON DC 20037 202-734-3400
Vanda Pharmaceuticals Inc. (Filer) CIK: 0001347178 (see all company filings)

IRS No.: 030491827 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS/A | Act: 34 | File No.: 001-34186 | Film No.: 24891439
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)